会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Thionosalicylic acid anilides and salts thereof
    • 硫代水杨酸苯胺及其盐
    • US3974204A
    • 1976-08-10
    • US549682
    • 1975-02-13
    • Jurgen KurzHeinrich KollingManfred Federmann
    • Jurgen KurzHeinrich KollingManfred Federmann
    • C07C153/067
    • New thionosalicylic acid anilides and salts with bases are provided which have parasiticidal activity in sheep and cattle particularly against adult liver flukes in sheep and cattle and other domestic animals, especially against juvenile liver flukes. The new compounds are produced by the reaction of poly-substituted phenols with substituted aromatic isothiocyanates, the hydrolysis products of oxo-thiono- or dithiono-dihydrobenzoxazines or by the reaction of N-phenyl-salicyl-imide chlorides with thio-compounds. Typical compounds are 3,5-dichloro-4'-bromo-thionosalicylic acid anilide and 2-acetoxy-3,5-dichloro-N-(2'-methyl-4'-chlorophenyl)-thionobenzamide. Novel benzoxazines obtainable from the above anilides are also provided and have similar properties. Typical compounds are 3-(3',5'-bis-trifluoromethyl-phenyl)-6,8-dibromo-2-oxo-4-thionodihydrobenzoxazine-(1,3), 3-(3',4'-dichlorophenyl)-6,8-dichloro-2,4-dithiono-dihydrobenzoxazine-(1,3) and 3-(4'-bromophenyl)-6-chloro-8-bromo-2,4-dithiono-dihydrobenzoxazine-(1,3). Methods for preparing a large number of both types of compounds are described. The compounds are administered orally or subcutaneously in doses of 2.5 to 100 mg/kg, preferably 5 to 15 mg/kg, of body weight.
    • 提供新的硫羟水杨酸和与碱的盐,其在绵羊和牛中具有杀寄生虫活性,特别是针对羊,牛和其他家畜中的成年肝吸虫,特别是针对幼鱼肝吸虫。 新化合物是通过多取代苯酚与取代的芳族异硫氰酸酯的反应,氧代 - 硫代 - 或二硫代 - 二氢苯并恶嗪的水解产物或N-苯基 - 水杨酰基酰亚胺氯化物与硫代化合物的反应制备的。 典型的化合物是3,5-二氯-4'-溴 - 硫代水杨酸酰苯胺和2-乙酰氧基-3,5-二氯-N-(2'-甲基-4'-氯苯基) - 硫代苯甲酰胺。 还提供了可从上述酰苯胺获得的新型苯并恶嗪,具有相似的性质。 典型的化合物是3-(3',5'-双 - 三氟甲基 - 苯基)-6,8-二溴-2-氧代-4-硫代二氢苯并恶嗪 - (1,3),3-(3',4'-二氯苯基 )-6,8-二氯-2,4-二硫代二氢苯并恶嗪 - (1,3)和3-(4'-溴苯基)-6-氯-8-溴-2,4-二硫代 - 二氢苯并恶嗪 - (1, 3)。 描述了制备大量两种类型化合物的方法。 化合物以2.5至100mg / kg,优选5至15mg / kg体重的剂量口服或皮下给药。
    • 5. 发明授权
    • 1-(4-Phenoxy-phenyl)-1,3,5-triazines
    • 1-(4-苯氧基 - 苯基)-1,3,5-三嗪
    • US3966725A
    • 1976-06-29
    • US559562
    • 1975-03-18
    • Josef Helmut ReisdorffGerd AichingerAxel HaberkornHeinrich KollingEckart Kranz
    • Josef Helmut ReisdorffGerd AichingerAxel HaberkornHeinrich KollingEckart Kranz
    • C07D251/34A23K1/16A61K31/53A61P33/02C07C273/18C07C275/36C07C319/20C07C323/20C07D251/38
    • C07D251/26A23K20/116C07C273/1827C07C319/20
    • 1-(4-Phenoxy-phenyl)-1,3,5-triazine derivatives of the formula ##SPC1##And pharmaceutically-acceptable, nontoxic salts thereof whereinR.sub.1 to R.sub.9 are the same or different and each is hydrogen, alkyl, haloalkyl, alkoxy, haloalkoxy, alkylthio, haloalkylthio, halo, nitro, cyano, amino, acylamino, alkoxycarbonylamino, carboxy, alkoxycarbonyl, carbamoyl, acyl, haloacyl, alkylsulphinyl, alkylsulphonyl, haloalkylsulphinyl, haloalkylsulphonyl or sulphamoyl; provided that at least one of R.sub.1 to R.sub.9 is haloalkyl, haloalkylthio, haloalkylsulphinyl or haloalkylsulphonyl;R.sub.10 is hydrogen, alkyl, cycloalkyl, haloalkyl, alkoxy, alkoxyalkyl, haloalkoxyalkyl, alkylthioalkyl, haloalkylthioalkyl, alkenyl, alkinyl, alkoxycarbonyl, alkylthiocarbonyl, alkylthiothiocarbonyl, acylamino, diacylamino, dialkylamino, polymethylene-imino, polymethylene-imino interrupted by a heteroatom, unsubstituted or substituted benzyl or unsubstituted or substituted aryl;R.sub.11 is hydrogen or alkyl; andY is oxygen or sulphur;Are useful in treating coccidiosis in humans and animals.
    • 1-(4-苯氧基 - 苯基)-1,3,5-三嗪衍生物及其药学上可接受的,其中R 1至R 9相同或不同并且各自为氢,烷基,卤代烷基,烷氧基,卤代烷氧基的非对映体 烷硫基,卤代烷硫基,卤素,硝基,氰基,氨基,酰氨基,烷氧基羰基氨基,羧基,烷氧基羰基,氨基甲酰基,酰基,卤代酰基,烷基亚磺酰基,烷基磺酰基,卤代烷基亚磺酰基,卤代烷基磺酰基或氨磺酰基。 条件是R 1至R 9中的至少一个为卤代烷基,卤代烷硫基,卤代烷基亚磺酰基或卤代烷基磺酰基; R 10为氢,烷基,环烷基,卤代烷基,烷氧基,烷氧基烷基,卤代烷氧基烷基,烷硫基烷基,卤代烷硫基烷基,烯基,炔基,烷氧基羰基,烷硫基羰基,烷基硫代羰基,酰氨基,二酰基氨基,二烷基氨基,聚亚甲基亚氨基,被杂原子中断的聚亚甲基亚氨基, 取代的苄基或未取代或取代的芳基; R11是氢或烷基; Y为氧或硫; 有用于治疗人类和动物的结核病。